Evidence map›Paper›PMID 38557793›Full record

ArticleAnnals of surgery2024

Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multicenter, Real-World Risk-Matched Analysis.

Chase J Wehrle, Mingyi Zhang, Mazhar Khalil, Alejandro Pita, Jamak Modaresi Esfeh, Teresa Diago-Uso, Jaekeun Kim, Federico Aucejo, David C H Kwon, Khaled Ali and 15 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
36.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Evolution of out-of-sequence liver allocation, 2019-2024.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Transplantation of older DCD livers in the machine perfusion era: a U.S. cohort study.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  13. Review
  14. Review
  15. Time as a Therapeutic Ally: The Promise of Long-Term Solid Organ and Tissue Perfusion.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 1 country.

Chase J WehrleTransplantation Center, Cleveland Clinic, OH.
Mingyi ZhangTransplantation Center, Cleveland Clinic, OH.
Mazhar KhalilTransplantation Center, Cleveland Clinic, OH.
Alejandro PitaTransplantation Center, Cleveland Clinic, OH.
Jamak Modaresi EsfehDepartment of Gastroenterology and Transplant Hepatology, Cleveland Clinic, Cleveland, OH.
Teresa Diago-UsoDepartment of Liver Transplantation, Cleveland Clinic Abu Dhabi, Cleveland, OH.
Jaekeun KimTransplantation Center, Cleveland Clinic, OH.
Federico AucejoTransplantation Center, Cleveland Clinic, OH.
David C H KwonTransplantation Center, Cleveland Clinic, OH.
Khaled AliTransplantation Center, Cleveland Clinic, OH.
Beatrice CazzanigaTransplantation Center, Cleveland Clinic, OH.
Yuki MiyazakiTransplantation Center, Cleveland Clinic, OH.
Qiang LiuTransplantation Center, Cleveland Clinic, OH.
Sami FaresTransplantation Center, Cleveland Clinic, OH.
Hanna HongTransplantation Center, Cleveland Clinic, OH.
Munkhbold TuulTransplantation Center, Cleveland Clinic, OH.
Chunbao JiaoDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland, OH.
Keyue SunDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland, OH.
Robert L FairchildDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland, OH.
Cristiano QuintiniDepartment of Liver Transplantation, Cleveland Clinic Abu Dhabi, Cleveland, OH.
Masato FujikiTransplantation Center, Cleveland Clinic, OH.
Antonio D PinnaTransplant Center, Cleveland Clinic Florida, Weston, FL.
Charles MillerTransplantation Center, Cleveland Clinic, OH.
Koji HashimotoTransplantation Center, Cleveland Clinic, OH.
Andrea SchlegelTransplantation Center, Cleveland Clinic, OH.
Cleveland Clinic · USCleveland Clinic Florida · USJPMorgan Chase & Co (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAssess cost and complication outcomes after liver transplantation (LT) using normothermic machine perfusion (NMP).

backgroundEnd-ischemic NMP is often used to aid logistics, yet its impact on outcomes after LT remains unclear, as does its true impact on costs associated with transplantation.

methodsDeceased donor liver recipients at 2 centers (January 1, 2019, to June 30, 2023) were included. Retransplants, splits, and combined grafts were excluded. End-ischemic NMP (OrganOx-Metra) was implemented in October 2022 for extended-criteria donation after brain death (DBDs), all donations after circulatory deaths (DCDs), and logistics. NMP cases were matched 1:2 with static cold storage controls (SCS) using the Balance-of-Risk [donation after brain death (DBD)-grafts] and UK-DCD Score (DCD-grafts).

resultsOverall, 803 transplantations were included, 174 (21.7%) receiving NMP. Matching was achieved between 118 NMP-DBDs with 236 SCS; and 37 NMP-DCD with 74 corresponding SCS. For both graft types, median inpatient comprehensive complications index values were comparable between groups. DCD-NMP grafts experienced reduced cumulative 90-day comprehensive complications index (27.6 vs 41.9, P =0.028). NMP also reduced the need for early relaparotomy and renal replacement therapy, with subsequently less frequent major complications (Clavien-Dindo ≥IVa). This effect was more pronounced in DCD transplants. NMP had no protective effect on early biliary complications. Organ acquisition/preservation costs were higher with NMP, yet NMP-treated grafts had lower 90-day pretransplant costs in the context of shorter waiting list times. Overall costs were comparable for both cohorts.

conclusionsThis is the first risk-adjusted outcome and cost analysis comparing NMP and SCS. In addition to logistical benefits, NMP was associated with a reduction in relaparotomy and bleeding in DBD grafts, and overall complications and post-LT renal replacement for DCDs. While organ acquisition/preservation was more costly with NMP, overall 90-day health care costs-per-transplantation were comparable.

Indexed as

Liver TransplantationOrgan PreservationPerfusionPostoperative ComplicationsAdultAgedFemaleGraft SurvivalHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID38557793
OpenAlexW4393388885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.